Assignee
KODIAK SCIENCES INC
US·13 granted patents·17 pending applications·82 citations·filing 2014–2024
Top patents by PatentIndex Score
30 records- 0196US11590235B2Factor VIII zwitterionic polymer conjugatesKODIAK SCIENCES INC·Filed 2020·Granted Feb 28, 2023·5 cites·15 claims
- 0295US10363290B2Butyrylcholinesterase zwitterionic polymer conjugatesKODIAK SCIENCES INC·Filed 2015·Granted Jul 30, 2019·11 cites·19 claims
- 0393US11071771B2Butyrylcholinesterase zwitterionic polymer conjugatesKODIAK SCIENCES INC·Filed 2019·Granted Jul 27, 2021·7 cites·26 claims
- 0493US9840553B2Dual PDGF/VEGF antagonistsKODIAK SCIENCES INC·Filed 2015·Granted Dec 12, 2017·18 cites·34 claims
- 0592US11155610B2Dual PDGF/VEGF antagonistsKODIAK SCIENCES INC·Filed 2017·Granted Oct 26, 2021·7 cites·22 claims
- 0692US10702608B2Factor VIII zwitterionic polymer conjugatesKODIAK SCIENCES INC·Filed 2014·Granted Jul 7, 2020·10 cites·20 claims
- 0791US11066465B2Antibodies and conjugates thereofKODIAK SCIENCES INC·Filed 2016·Granted Jul 20, 2021·9 cites·15 claims
- 0889US11819531B2Multifunctional zwitterionic polymer conjugatesKODIAK SCIENCES INC·Filed 2016·Granted Nov 21, 2023·3 cites·21 claims
- 0989US11584790B2Complement factor D antagonist antibodies and conjugates thereofKODIAK SCIENCES INC·Filed 2018·Granted Feb 21, 2023·8 cites·45 claims
- 1086US2024197810A1Multifunctional zwitterionic polymer conjugatesKODIAK SCIENCES INC·Filed 2023·Application pending·0 cites
- 1184US2024293585A1High molecular weight zwitterion-containing polymersKODIAK SCIENCES INC·Filed 2024·Application pending·0 cites
- 1283US11912784B2Methods of treating an eye disorderKODIAK SCIENCES INC·Filed 2020·Granted Feb 27, 2024·2 cites·43 claims
- 1380US12214044B2Factor VIII zwitterionic polymer conjugatesKODIAK SCIENCES INC·Filed 2023·Granted Feb 4, 2025·0 cites·15 claims
- 1477US12071476B2IL-6 antibodies and fusion constructs and conjugates thereofKODIAK SCIENCES INC·Filed 2019·Granted Aug 27, 2024·2 cites·39 claims
- 1576US2022096643A1Acryloyloxyethylphosphorylcholine Containing Polymer Conjugates And Their PreparationKODIAK SCIENCES INC·Filed 2021·Application pending·0 cites
- 1674US12466879B2Complement factor D antagonist antibodies and conjugates thereofKODIAK SCIENCES INC·Filed 2023·Granted Nov 11, 2025·0 cites·22 claims
- 1773US2021402015A1High molecular weight zwitterion-containing polymersKODIAK SCIENCES INC·Filed 2021·Application pending·0 cites
- 1869US2024368267A1Il-6 antibodies and fusion constructs and conjugates thereofKODIAK SCIENCES INC·Filed 2024·Application pending·0 cites
- 1967US2020171179A1High molecular weight zwitterion-containing polymersKODIAK SCIENCES INC·Filed 2020·Application pending·0 cites
- 2065US2024084043A1Methods of treating an eye disorderKODIAK SCIENCES INC·Filed 2023·Application pending·0 cites
- 2165US2020000930A1Acryloyloxyethylphosphorylcholine Containing Polymer Conjugates And Their PreparationKODIAK SCIENCES INC·Filed 2019·Application pending·0 cites
- 2264US2017143841A1High molecular weight zwitterion-containing polymersKODIAK SCIENCES INC·Filed 2016·Application pending·0 cites
- 2363US2025388568A1Nlrp3 inhibitorsKODIAK SCIENCES INC·Filed 2023·Application pending·0 cites
- 2462US2020262905A1Dual pdgf/vegf antagonistsKODIAK SCIENCES INC·Filed 2020·Application pending·0 cites
- 2560US2021324063A1Antibodies and conjugates thereofKODIAK SCIENCES INC·Filed 2021·Application pending·0 cites
- 2658US2017007710A1Targeted drug phosphorylcholine polymer conjugatesKODIAK SCIENCES INC·Filed 2016·Application pending·0 cites
- 2758US2026022168A1Method of concentrating a solution or formulationKODIAK SCIENCES INC·Filed 2023·Application pending·0 cites
- 2852US2024209076A1Use of il-6 antibodies and vegf traps, and fusion constructs and conjugates thereofKODIAK SCIENCES INC·Filed 2021·Application pending·0 cites
- 2952US2023250133A1Methods of purifying a productKODIAK SCIENCES INC·Filed 2023·Application pending·0 cites
- 3051US2024238427A1Methods of treating an eye disorderKODIAK SCIENCES INC·Filed 2022·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →